Literature DB >> 16191686

Classification of Marek's disease viruses according to pathotype: philosophy and methodology.

R L Witter1, B W Calnek, C Buscaglia, I M Gimeno, K A Schat.   

Abstract

The concept of pathotype in Marek's disease (MD) probably dates from the recognition of a more virulent form of the disease in the late 1950s (Benton & Cover, 1957). Distinctions between MD virus strains were further expanded with the description of the vv pathotype in the early 1980s and of the vv+ pathotype in the 1990s. Pathotype designations reflect important biological properties that correlate with the break-through of vaccinal immunity in the field. However, pathotyping methods applied by various laboratories have not been uniform, preventing critical comparison of results. Better uniformity of pathotyping procedures is desirable.The Avian Disease and Oncology Laboratory (ADOL) method is based on induction of lymphoproliferative lesions in vaccinated chickens. This method has been used to pathotype more than 45 isolates and is the basis for the current pathotype classification of MD virus strains. Its limitations include requirements for a specific type of chickens (15x7 ab+), large numbers of animals, and a statistical method to compare lesion responses to those of JM/102W and Md5 control strains. Because of these limitations, it has not been and is not likely to be used in other laboratories. Comparability in pathotyping can be improved by the comparison of field isolates with standard prototype strains such as JM/102W, Md5 and 648A (American Type Culture Collection) or their equivalents. Data may be generated by different in vivo procedures that measure tumour induction, neurological disease (both neoplastic and non-neoplastic lesions), or solely non-neoplastic criteria (such as lymphoid organ weights or virus replication). Methods based on neoplastic criteria, especially when generated in MD-immunized chickens, will probably correlate most closely with that of the ADOL method and be most relevant to evolution of MD virus in the field. Based on data from several trials, a modification of the ADOL method that utilizes fewer chickens and can be conducted with commercial specific pathogen free strains is proposed. The modified method is based on "best fit" comparisons with prototype strains, and is expected to provide results generally comparable with the original method. A variety of other alternative criteria (see earlier) are also evaluated both for primary pathotyping and as adjuncts to other pathotyping methods. Advantages and disadvantages of alternative methods are presented.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16191686     DOI: 10.1080/03079450500059255

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  40 in total

1.  Clustering of mutations within the inverted repeat regions of a serially passaged attenuated gallid herpesvirus type 2 strain.

Authors:  Stephen J Spatz; Cary Rue; Daniel Schumacher; Nikolaus Osterrieder
Journal:  Virus Genes       Date:  2008-05-31       Impact factor: 2.332

2.  Marek's disease virus in vaccinated poultry flocks in Turkey: its first isolation with molecular characterization.

Authors:  Emre Ozan; Bahadir Muftuoglu; Ismail Sahindokuyucu; Hanne Nur Kurucay; Sinem Inal; Nilufer Kuruca; Ahmed Eisa Elhag; Efe Karaca; Cuneyt Tamer; Semra Gumusova; Harun Albayrak; Gerald Barry; Mustafa Yavuz Gulbahar; Zafer Yazici
Journal:  Arch Virol       Date:  2021-01-06       Impact factor: 2.574

3.  Genome sequence determination and analysis of a Chinese virulent strain, LMS, of Gallid herpesvirus type 2.

Authors:  Yun Cheng; Feng Cong; Yan-ping Zhang; Zhi-jie Li; Na-na Xu; Guang-yu Hou; Chang-Jun Liu
Journal:  Virus Genes       Date:  2012-04-04       Impact factor: 2.332

4.  Marek's Disease Virus Disables the ATR-Chk1 Pathway by Activating STAT3.

Authors:  Xue Lian; Chenyi Bao; Xueqi Li; Xunhai Zhang; Hongjun Chen; Yong-Sam Jung; Yingjuan Qian
Journal:  J Virol       Date:  2019-04-17       Impact factor: 5.103

5.  Molecular and pathogenicity characterization of Gallid herpesvirus 2 newly isolated in China from 2009 to 2013.

Authors:  Yan-Ping Zhang; Hong-Chao Lv; Ke-Yan Bao; Yu-Long Gao; Hong-Lei Gao; Xiao- le Qi; Hong-Yu Cui; Yong-Qiang Wang; Kai Li; Li Gao; Xiao-Mei Wang; Chang-Jun Liu
Journal:  Virus Genes       Date:  2015-11-26       Impact factor: 2.332

6.  Sequence determination of a mildly virulent strain (CU-2) of Gallid herpesvirus type 2 using 454 pyrosequencing.

Authors:  Stephen J Spatz; Cary A Rue
Journal:  Virus Genes       Date:  2008-03-20       Impact factor: 2.332

7.  Marek's disease viral interleukin-8 promotes lymphoma formation through targeted recruitment of B cells and CD4+ CD25+ T cells.

Authors:  Annemarie T Engel; Ramesh K Selvaraj; Jeremy P Kamil; Nikolaus Osterrieder; Benedikt B Kaufer
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

8.  Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus.

Authors:  Andrew C Brown; Susan J Baigent; Lorraine P Smith; Jason P Chattoo; Lawrence J Petherbridge; Pippa Hawes; Martin J Allday; Venugopal Nair
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-30       Impact factor: 11.205

9.  Isolation and analysis of a very virulent Marek's disease virus strain in China.

Authors:  Zhenhua Gong; Lijuan Zhang; Jianlin Wang; Linlin Chen; Hu Shan; Zhiliang Wang; Hongchao Ma
Journal:  Virol J       Date:  2013-05-20       Impact factor: 4.099

10.  Genetic evolution of Marek's disease virus in vaccinated poultry farms.

Authors:  Nahed Yehia; Hemat S El-Sayed; Sabry E Omar; Ahmed Erfan; Fatma Amer
Journal:  Vet World       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.